As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...
A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.
With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of ...
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...
This story was originally published by The Imprint, a national nonprofit news outlet covering child welfare and youth justice ...
"The thing about libido is that it's always changing and affected by day-to-day life, along with your history. Your libido ...
Montreal-based content creator Zoe Morgan went from getting “stares of admiration” to “stares of contempt," she tells PEOPLE ...
"The thing about libido is that it's always changing and affected by day-to-day life, along with your history. Your libido ...
5d
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any ...
West Hollywood moves toward legal protections for polyamorous relationships, which can face systemic barriers in housing, ...
After graduating from Temple University in 2023, the South Philadelphia local was finding her footing in post-grad life while ...
Montreal-based content creator Zoe Morgan went from getting “stares of admiration” to “stares of contempt," she tells PEOPLE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results